Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 353,705 | 349,563 | 278,288 | N/A | N/A |
| Depreciation Amortization | 220,507 | 168,116 | 55,775 | N/A | N/A |
| Income taxes - deferred | -16,677 | 43,484 | -11,892 | N/A | N/A |
| Other Working Capital | -20,056 | -176,263 | -28,829 | N/A | N/A |
| Other Operating Activity | 30,847 | -423 | -52,751 | 0 | 0 |
| Operating Cash Flow | $568,326 | $384,477 | $240,591 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,597 | -3,915 | -4,292 | N/A | N/A |
| Net Acquisitions | N/A | -1,362,704 | N/A | N/A | N/A |
| Purchase Of Investment | -13,080 | N/A | -81 | N/A | N/A |
| Purchase Sale Intangibles | -415,399 | -927,654 | -61,851 | N/A | N/A |
| Other Investing Activity | -415,399 | -927,654 | -61,871 | 0 | 0 |
| Investing Cash Flow | $-432,076 | $-2,294,273 | $-66,244 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,479,675 | 1,679,575 | N/A | N/A | N/A |
| Debt Repayment | -1,637,943 | N/A | -236 | N/A | N/A |
| Other Financing Activity | -12,862 | -10,051 | 0 | 0 | 0 |
| Financing Cash Flow | $-171,130 | $1,669,524 | $-236 | $N/A | $N/A |
| Exchange Rate Effect | -1,417 | 952 | 849 | N/A | N/A |
| Beginning Cash Position | 80,333 | 317,294 | 170,175 | N/A | N/A |
| End Cash Position | 44,036 | 77,975 | 345,155 | N/A | N/A |
| Net Cash Flow | $-36,297 | $-239,320 | $174,980 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 568,326 | 384,477 | 240,591 | N/A | N/A |
| Capital Expenditure | -4,469 | -3,915 | -4,663 | N/A | N/A |
| Free Cash Flow | 563,857 | 380,563 | 235,928 | 0 | 0 |